CLINICAL AND ECHOCARDIOGRAPHIC FEATURES OF SEVERE CONGESTIVE-HEART-FAILURE ACCORDING TO DIFFERENT PATHOGENETIC MECHANISM

被引:0
|
作者
FAGGIANO, P [1 ]
RUSCONI, C [1 ]
GHIZZONI, G [1 ]
SABATINI, T [1 ]
SORGATO, A [1 ]
SIMONCELLI, U [1 ]
机构
[1] ST ORSOLA HOSP,CORONARY CARE UNIT,I-25133 BRESCIA,ITALY
来源
ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY | 1992年 / 4卷 / 04期
关键词
DIASTOLIC DYSFUNCTION; CONGESTIVE HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure (CHF) may be caused by systolic dysfunction (SD) of the left ventricle (LV) or isolated diastolic dysfunction (DD). Differentiation between SD and DD is important because each one requires a different form of therapy. In order to evaluate if some clinical and/or echocardiographic differences exist between patients(pts) with CHF from SD or DD we have analysed a group of 120 pts admitted to our Division with severe CHF (NYHA III-IV). After clinical evaluation all pts underwent a complete Echo-Doppler examination at the time of admission. SD was considered present if LV end-diastolic diameter (LVEDD) greater-than-or-equal-to 56 mm and LV fractional shortening (FS %) < 25%. DD was considered present if LVEDD and FS were both within a normal range. Furthermore, wall thickness and LV filling by Doppler Transmitral flow during early filling (Evel) and atrial contraction (Avel) were measured. Results: CHF was caused by SD in 90 pts (75%) and by DD in 30 pts (25%), p < 0.001. SD was due to dilated cardiomyopathy (83 pts), ischemic or idiopathic, and to severe aortic stenosis (7 pts); DD was due to aortic stenosis (20 pts), hypertrophic cardiomyopathy (4 pts) and hypertensive cardiopathy (6 pts).
引用
收藏
页码:309 / 314
页数:6
相关论文
共 50 条
  • [31] THE PHARMACOKINETICS OF QUINAPRIL AND QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    BEGG, EJ
    ROBSON, RA
    IKRAM, H
    RICHARDS, AM
    BAMMERTADAMS, JA
    OLSON, SC
    POSVAR, EL
    REECE, PA
    SEDMAN, AJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (03) : 302 - 304
  • [32] ACUTE AND CHRONIC EFFICACY OF FELODIPINE IN CONGESTIVE-HEART-FAILURE
    AGOSTONI, P
    DORIA, E
    RIVA, S
    POLESE, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1991, 30 (01) : 89 - 95
  • [33] HEMOPTYSIS IN A PATIENT WITH CONGESTIVE-HEART-FAILURE AND PULMONARY EMBOLI
    CHANG, JC
    CREGLER, LL
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1994, 86 (05) : 383 - 386
  • [34] NEW THERAPEUTIC STRATEGIES IN THE MANAGEMENT OF CONGESTIVE-HEART-FAILURE
    BRUNELLI, C
    GHIGLIOTTI, G
    MARTINI, U
    CAPONNETTO, S
    EUROPEAN HEART JOURNAL, 1991, 12 : 53 - 57
  • [36] CALCIUM CURRENT IN CONGESTIVE-HEART-FAILURE OF HAMSTER CARDIOMYOPATHY
    ROSSNER, KL
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (04): : H1179 - H1186
  • [37] HEMODYNAMIC-RESPONSE TO INTRAVENOUS ENALAPRILAT IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE AND MITRAL REGURGITATION
    VARRIALE, P
    DAVID, W
    CHRYSSOS, BE
    CLINICAL CARDIOLOGY, 1993, 16 (03) : 235 - 238
  • [38] PHARMACOKINETICS OF FLOSEQUINAN IN ELDERLY PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE
    SAKAI, M
    OHKAWA, S
    KAKU, T
    KUBOKI, K
    CHIDA, K
    IMAI, T
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) : 387 - 389
  • [39] ATRIOVENTRICULAR PLANE DISPLACEMENT IN SEVERE CONGESTIVE-HEART-FAILURE FOLLOWING DILATED CARDIOMYOPATHY OR MYOCARDIAL-INFARCTION
    ALAM, M
    HOGLUND, C
    THORSTRAND, C
    PHILIP, A
    JOURNAL OF INTERNAL MEDICINE, 1990, 228 (06) : 569 - 575
  • [40] THYROTOXICOSIS-INDUCED CONGESTIVE-HEART-FAILURE IN AN URBAN HOSPITAL
    WILSON, BE
    NEWMARK, SR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1994, 308 (06) : 344 - 348